Inhibition of neutrophil function by fluid phase C3b of complement

A high-molecular-weight fragment of C3 was isolated from normal human serum by column chromatography, was generated by incubation of serum at 37 degrees C with inulin, and was produced from highly purified C3 by limited digestion with trypsin. This product was shown to inhibit the antibacterial function of neutrophils by using Escherichia coli O75 as the main test organism. The inhibitor reacted with anti-C3b and anti-C3c, but not with anti-C3B (anti-native C3) or anti-C3a. The manner of preparation of the inhibitor, the sodium dodecyl sulfate-polyacrylamide gel electrophoresis pattern, and the amino acid composition of the inhibitor indicated that it was fluid phase C3b. The inhibitor of neutrophil function (fluid phase C3b) was shown to bind to C3b receptors or acceptors on sheep erythrocytes in a model system.

[1]  H. Colten,et al.  Complement (C3b) interaction with the human granulocyte receptor: correlation of binding of fluid-phase radiolabeled ligand with histaminase release. , 1982, Journal of immunology.

[2]  J. Lambris,et al.  Assay of membrane complement receptors (CR1 and CR2) with C3b- and C3d-coated fluorescent microspheres. , 1982, Journal of immunology.

[3]  H. Colten,et al.  Characterization of the human complement (c3b) receptor with a fluid phase C3b dimer. , 1981, Journal of immunology.

[4]  M. Frank,et al.  Lack of binding of human C3, in its native state, to C3b receptors. , 1981, Journal of immunology.

[5]  M. Daha,et al.  Participation of immunoglobulins and complement components in the intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes , 1981, Infection and immunity.

[6]  M. Pangburn,et al.  Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties. , 1981, Biochemistry.

[7]  M. Dierich,et al.  Qualitative and quantitative assessment of C3-receptor reactivities on lymphoid and phagocytic cells. , 1981, Journal of immunology.

[8]  H. Gresham,et al.  Large scale isolation of functionally active components of the human complement system. , 1981, The Journal of biological chemistry.

[9]  M. Thomas,et al.  Evidence for presence of an internal thiolester bond in third component of human complement. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Pangburn,et al.  Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement , 1980, The Journal of experimental medicine.

[11]  A. Schechter,et al.  Third component of human complement: appearance of a sulfhydryl group following chemical or enzymatic inactivation. , 1980, Biochemistry.

[12]  K. Austen,et al.  Functional discrimination by human monocytes between their C3b receptors and their recognition units for particulate activators of the alternative complement pathway. , 1980, Journal of immunology.

[13]  D. Fearon.  Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte , 1980, The Journal of experimental medicine.

[14]  H. Chaplin,et al.  A simple method for preparation of C3c fragment from trypsinized serum‐ reacted zymosan , 1980, Transfusion.

[15]  F. Joisel,et al.  Preparation of an R3 reagent (serum depleted of the third component of human complement (C3)) by immunoadsorption. Application to the hemolytic assay of human C3. , 1980, Journal of immunological methods.

[16]  H. Verbrugh,et al.  Quantitation of the Third Component of Human Complement Attached to the Surface of Opsonized Bacteria: Opsonin-Deficient Sera and Phagocytosis-Resistant Strains , 1979, Infection and immunity.

[17]  R. Johnston,et al.  Role of binding through C3b and IgG in polymorphonuclear neutrophil function: studies with trypsin-generated C3b. , 1979, Journal of immunology.

[18]  H. Müller-Eberhard,et al.  C3e: an acidic fragment of human C3 with leukocytosis-inducing activity. , 1979, Journal of immunology.

[19]  B. Tack,et al.  Third component of human complement: structural analysis of the polypeptide chains of C3 and C3b. , 1979, Biochemistry.

[20]  M. Dierich,et al.  Complement bridges between cells analysis of a possible cell-cell interaction mechanism , 1977, The Journal of experimental medicine.

[21]  R. Schreiber,et al.  Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution , 1977, The Journal of experimental medicine.

[22]  R. Levine,et al.  Interaction between the third complement protein and cell surface macromolecules. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Dierich,et al.  Receptor-binding sites on C3 and C3b. , 1977, Journal of immunology.

[24]  V. Nussenzweig,et al.  The role of membrane receptors for C3b and C3d in phagocytosis , 1977, The Journal of experimental medicine.

[25]  T. Hugli.  Human anaphylatoxin (C3a) from the third component of complement. Primary structure. , 1975, Journal of Biological Chemistry.

[26]  J. Gitlin,et al.  The mechanism of action of the C3b inactivator (conglutinogen- activating factor) on its naturally occurring substrate, the major fragment of the third component of complement (C3b) , 1975, The Journal of experimental medicine.

[27]  J. Wilson,et al.  The identification of Fc and C3 receptors on human neutrophils. , 1975, Journal of immunological methods.

[28]  P. Cuatrecasas,et al.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography. , 1974, Analytical biochemistry.

[29]  M. Mayer,et al.  Kinetic studies of the formation of the properdin system enzymes on zymosan: evidence that nascent C3b controls the rate of assembly. , 1974, Journal of immunology.

[30]  A. G. Osler,et al.  Lysosomal enzyme release from human leukocytes: mediation by the alternate pathway of complement activation. , 1973, Journal of immunology.

[31]  J. Molenaar,et al.  Anti-C3a, anti-C3B (anti-B) and their reaction with the anaphylatoxic fragment C3a. , 1973, Journal of immunology.

[32]  J. Meakins,et al.  A Physiological Basis for the Development of Opportunistic Infections in Man , 1972, Annals of surgery.

[33]  H. Müller-Eberhard,et al.  A fragment of the third component of human complement with anaphylatoxin activity. , 1971, Biochemistry.

[34]  K. Weber,et al.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. , 1969, The Journal of biological chemistry.

[35]  J. Heremans,et al.  Immunochemical quantitation of antigens by single radial immunodiffusion. , 1965, Immunochemistry.

[36]  William W. Cohen,et al.  The preparation and properties of two new chromogenic substrates of trypsin. , 1961, Archives of biochemistry and biophysics.

[37]  R. Schreiber,et al.  Molecular biology and chemistry of the alternative pathway of complement. , 1980, Advances in immunology.

[38]  G. D. Ross.  Analysis of the different types of leukocyte membrane complement receptors and their interaction with the complement system. , 1980, Journal of immunological methods.

[39]  J. Alexander,et al.  Improved tests for the evaluation of neutrophil function in human disease. , 1968, The Journal of laboratory and clinical medicine.

[40]  J. Scheidegger.  Une micro-méthode de l’immuno-électrophorèse , 1955 .